Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone
- PMID: 8636281
- DOI: 10.1210/jcem.81.2.8636281
Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone
Abstract
The spontaneous growth process in Turner's syndrome is characterized by a progressive decline in height velocity during childhood and no pubertal growth spurt. Therefore, therapy aimed at improving height during childhood as well as increasing final height is desirable for most girls with Turner's syndrome. Forty-five girls with Turner's syndrome, 9-16 yr of age (mean age, 12.2 yr), were allocated to three study groups. Group 1 (n = 13) was initially treated with oxandrolone alone; after 1 yr of treatment, GH without (group 1a; n = 6) or with (group 1b; n = 7) ethinyl estradiol was added. Group 2 (n = 17) was treated with GH plus oxandrolone. Group 3 (n = 15) was treated with GH, oxandrolone, and ethinyl estradiol. The dosage were: GH, 0.1 IU/kg.day; oxandrolone, 0.05 mg/kg.day; and ethinyl estradiol, 100 ng/kg.day. A height of 150 cm or more was achieved in 61%, 75%, and 60% of the girls in groups 1, 2, and 3, respectively. The most impressive increase in height was seen in group 2. In this group the mean final height was 154.2 cm (SD = 6.6), which is equivalent to a mean net gain of 8.5 cm (SD = 4.6) over the projected final height. In group 3, in which ethinyl estradiol was included from the start of therapy, the initially good height velocity decelerated after 1-2 yr of treatment. Their mean final height was 151.1 (SD = 4.6) cm, equivalent to a mean net gain of 3.0 cm (SD = 3.8). A similar growth-decelerating effect of ethinyl estradiol was seen in group 1b. We conclude that in girls with Turner's syndrome who are older than 9 yr of age, treatment with GH in combination with oxandrolone results in significant growth acceleration, imitating that in normal puberty, leading to a more favorable height during childhood. This mode of treatment also results in a significantly increased final height, permitting a great number of the girls to attain a final height of more than 150 cm. However, early addition of estrogen decelerates the height velocity and reduces the gain in height.
Similar articles
-
Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.J Clin Endocrinol Metab. 1999 Dec;84(12):4510-5. doi: 10.1210/jcem.84.12.6175. J Clin Endocrinol Metab. 1999. PMID: 10599710 Clinical Trial.
-
Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.Acta Paediatr Suppl. 1992 Sep;383:3-6; discussion 7. Acta Paediatr Suppl. 1992. PMID: 1458013 Clinical Trial.
-
Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.J Clin Endocrinol Metab. 1990 Jan;70(1):122-6. doi: 10.1210/jcem-70-1-122. J Clin Endocrinol Metab. 1990. PMID: 2294126 Clinical Trial.
-
[Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences].Ugeskr Laeger. 1992 Jun 15;154(25):1773-8. Ugeskr Laeger. 1992. PMID: 1632017 Review. Danish.
-
Optimization of treatment in Turner's syndrome.J Pediatr Endocrinol Metab. 2004 Mar;17 Suppl 3:427-34. J Pediatr Endocrinol Metab. 2004. PMID: 15134303 Review.
Cited by
-
White matter microstructural abnormalities in girls with chromosome 22q11.2 deletion syndrome, Fragile X or Turner syndrome as evidenced by diffusion tensor imaging.Neuroimage. 2013 Nov 1;81:441-454. doi: 10.1016/j.neuroimage.2013.04.028. Epub 2013 Apr 18. Neuroimage. 2013. PMID: 23602925 Free PMC article.
-
Value of growth hormone treatment in Turner's syndrome.Endocrine. 2000 Apr;12(2):183-7. doi: 10.1385/ENDO:12:2:183. Endocrine. 2000. PMID: 10905378 Review. No abstract available.
-
Height outcome of the recombinant human growth hormone treatment in Turner syndrome: a meta-analysis.Endocr Connect. 2018 Apr;7(4):573-583. doi: 10.1530/EC-18-0115. Epub 2018 Mar 26. Endocr Connect. 2018. PMID: 29581156 Free PMC article.
-
Advances in endocrinology.Arch Dis Child. 1998 Mar;78(3):278-84. doi: 10.1136/adc.78.3.278. Arch Dis Child. 1998. PMID: 9613366 Free PMC article. Review.
-
Optimising management in Turner syndrome: from infancy to adult transfer.Arch Dis Child. 2006 Jun;91(6):513-20. doi: 10.1136/adc.2003.035907. Arch Dis Child. 2006. PMID: 16714725 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical